PARKINSON’S DISEASE, CAUSES OF PARKINSON’S DISEASE, AND TREATMENT METHODS

Authors

  • Tolipova Rukhshona Muhammadjon qizi,Karabaev Abdumalik Kokand University, Andijan Branch, Faculty of Medicine "General Medicine" program, 2nd year, Group 24-23 Student,Scientific Supervisor

Keywords:

Parkinson's disease, dopamine, central nervous system, treatment, prevention, neurodegeneration, deep brain stimulation, motor symptoms, non-motor symptoms, quality of life.

Abstract

This article is devoted to Parkinson's disease, its causes, and treatment methods [1, 2, 5]. Parkinson's disease is a chronic degenerative disorder of the central nervous system, primarily caused by dopamine deficiency [3, 4, 10]. The disease usually develops gradually and manifests through symptoms such as tremors, muscle stiffness, and slowed movements [1, 6, 9]. The article analyzes the factors contributing to the development of Parkinson's disease, including genetic predisposition, environmental factors, and neurochemical changes [2, 4, 7]. In addition, information about pharmacological therapy, physiotherapy, deep brain stimulation, and lifestyle-based preventive measures is provided [7, 8, 10]. The study aims to improve early diagnosis, reduce symptoms, and enhance patients' quality of life [3, 6, 8]. The article may be useful for neurologists, general practitioners, and healthcare professionals [1, 5, 9].

Downloads

Download data is not yet available.

References

Kalia, L.V., & Lang, A.E. (2015). Parkinson's disease. The Lancet, 386(9996), 896–912.

Dauer, W., & Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron, 39(6), 889–909.

Poewe, W., Seppi, K., Tanner, C.M., Halliday, G.M., Brundin, P., Volkmann, J., et al. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 17013.

Schapira, A.H.V., & Jenner, P. (2011). Etiology and pathogenesis of Parkinson's disease. Movement Disorders, 26(6), 1049–1055.

Hirsch, E.C., & Hunot, S. (2009). Neuroinflammation in Parkinson's disease: a target for neuroprotection? The Lancet Neurology, 8(4), 382–397.

National Institutes of Health (NIH). (2019). Parkinson's Disease Fact Sheet. Bethesda, MD: NIH.

Kalia, L.V., & Lang, A.E. (2016). Treatment of Parkinson's disease: an overview. The Lancet, 388(10039), 1077–1089.

Olanow, C.W., Stern, M.B., & Sethi, K. (2009). The scientific and clinical basis for the treatment of Parkinson's disease. Neurology, 72(Suppl 2), S1–S136.

de Lau, L.M.L., & Breteler, M.M.B. (2006). Epidemiology of Parkinson's disease. The Lancet Neurology, 5(6), 525–535.

World Health Organization (WHO). (2020). Neurological Disorders: Public Health Challenges. Geneva: WHO.

Downloads

Published

2026-01-22

How to Cite

Tolipova Rukhshona Muhammadjon qizi,Karabaev Abdumalik. (2026). PARKINSON’S DISEASE, CAUSES OF PARKINSON’S DISEASE, AND TREATMENT METHODS. Journal of Applied Science and Social Science, 16(01), 513–517. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/3027

Issue

Vol. 16 No. 01 (2026): Volume 16 Issue 01

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.